Veristat knows that in order to succeed as a full service contract research organization it is vital to distinguish itself in this industry. Many sources have looked to contract research organizations to continue growing and according to the article, Playing Big Pharma with CRO’s, this trend will continue. As a mid-sized, full service CRO Veristat is able to closely monitor costs and maximize efficiencies for pharmaceutical, biotech and medical device companies. As this article shows, outsourcing to a CRO will provide greater efficiencies to a company’s bottom line and to their drug development programs.
Our size, in comparison to larger competitors, allows Veristat to be an extension of your organization and a partner to your team. This is especially beneficial in allowing your company to specialize in the areas of drug development expertise while Veristat assists you in running your clinical programs. All the while we create maximum efficiencies, provide you with excellence from our teams, and monitor costs to help keep your clinical study in budget.
Our clinical trial partnerships begin with strategic consulting and medical writing of your protocols and continue on to encompass clinical monitoring, data management, biostatistical analysis, programming, FDA representation, and CDISC Implementation.
For more information on Veristat please contact Cindy Henderson at info@veristat.com